Lateral Flow Immunochromatography Assay For Host Biomarkers Of Respiratory Infection
QXA is the FDA product code for Lateral Flow Immunochromatography Assay For Host Biomarkers Of Respiratory Infection, a class II device type, regulated under 21 CFR 866.3230. FDA's definition for this code reads: "A device to detect and measure non-microbial analytes to aid in the detection and identification of localized human infections is identified as an in vitro device intended for the detection and qualitative measurement, quantitative measurement, or both of one or more non-microbial analytes in human clinical specimens...". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- QXA
- Device name
- Lateral Flow Immunochromatography Assay For Host Biomarkers Of Respiratory Infection
- FDA definition
- A device to detect and measure non-microbial analytes to aid in the detection and identification of localized human infections is identified as an in vitro device intended for the detection and qualitative measurement, quantitative measurement, or both of one or more non-microbial analytes in human clinical specimens to aid in the assessment, identification, or both of a localized microbial infection when used in conjunction with clinical signs and symptoms and other clinical and laboratory findings.
- Regulation
- 21 CFR 866.3230
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code QXA
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2023 | 1 |
| 2026 | 1 |
Applicants with the most clearances
Product code QXA| Applicant | Clearances |
|---|---|
| Lumos Diagnostics, Inc. | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
